Pacira Biosciences Inc PCRX:NASDAQ

Earnings Announcement Next Earnings date is expected on 08/03/2021
Last Price$58.95NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/30/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$58.95 (13)
Ask (Size)$59.03 (1)
Day Low / HighN/A - N/A
Volume384.3 K

View Pharmaceuticals: Other IndustryPeer Comparison as of 07/30/2021


Pacira Biosciences Inc ( NASDAQ )

Price: $58.95
Change: -1.13 (1.88%)
Volume: 384.3 K
4:00PM ET 7/30/2021

Prestige Consumer Healthcare Inc ( NYSE )

Price: $52.55
Change: +0.02 (0.04%)
Volume: 188.9 K
7:00PM ET 7/30/2021

SAGE Therapeutics Inc ( NASDAQ )

Price: $43.73
Change: -0.40 (0.91%)
Volume: 889.0 K
3:59PM ET 7/30/2021

Cassava Sciences Inc ( NASDAQ )

Price: $69.53
Change: -33.82 (32.72%)
Volume: 25.2 M
3:59PM ET 7/30/2021

Corcept Therapeutics Inc ( NASDAQ )

Price: $20.77
Change: +0.48 (2.37%)
Volume: 748.6 K
3:59PM ET 7/30/2021

Read more news Recent News

JPMorgan Upgrades Pacira BioSciences to Overweight From Neutral; Price Target is $75
7:19AM ET 7/26/2021 MT Newswires

Pacira BioSciences (PCRX) has an average rating of outperform and price targets ranging from $54 to $94, according to analysts polled by Capital IQ. (MT...

Pacira BioSciences Reports Higher Q2 Revenue on Increased Exparel Sales
8:55AM ET 7/13/2021 MT Newswires

Pacira BioSciences (PCRX) reported Tuesday preliminary unaudited Q2 revenue of $135.6 million. Analysts polled by Capital IQ had projected Q2 sales of...

Pacira BioSciences Signs Exparel Distribution Agreement With Eurofarma in Latin America
8:52AM ET 6/22/2021 MT Newswires

Pacira BioSciences (PCRX) said Tuesday it has entered into a distribution agreement with Eurofarma Laboratories for the development and commercialization...

Insider Trends: Pacira Biosciences Insider Extends 90-Day Selling Trend
6:09PM ET 6/10/2021 MT Newswires

On Jun 08, 2021, Dr Donald C Manning, Chief Medical Officer, reported a sale of 2,600 shares in Pacira Biosciences (PCRX) for $158,964. Following the Form...

Company Profile

Business DescriptionPacira Biosciences, Inc. is a holding company, which provide non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam.The company was founded in December 2006 and is headquartered in Parsippany, NJ. View company web site for more details
Address5 Sylvan Way
Parsippany, New Jersey 07054
Number of Employees518
Recent SEC Filing06/17/20218-K
Chairman, Chief Executive & Operating OfficerDavid M. Stack
Chief Financial OfficerCharles A. Reinhart
Chief Medical OfficerRoy Winston
Chief Technical OfficerCharles Anthony Laranjeira

Company Highlights

Price Open$59.61
Previous Close$60.08
52 Week Range$48.23 - 80.00
Market Capitalization$2.6 B
Shares Outstanding44.0 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement08/03/2021

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings17.76
Earnings per Share$3.55
Beta vs. S&P 500N/A
Revenue$337.3 M
Net Profit Margin33.35%
Return on Equity26.34%

Analyst Ratings as of 07/23/2021

Consensus RecommendationConsensus Icon
Powered by Factset